Sun Pharm Industries Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDUSTRIES, and when can generic versions of SUN PHARM INDUSTRIES drugs launch?
SUN PHARM INDUSTRIES has one hundred and sixty-seven approved drugs.
There is one US patent protecting SUN PHARM INDUSTRIES drugs. There are two tentative approvals on SUN PHARM INDUSTRIES drugs.
There are twenty-two patent family members on SUN PHARM INDUSTRIES drugs in eighteen countries and one hundred and twenty-seven supplementary protection certificates in sixteen countries.
Summary for Sun Pharm Industries
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 100 |
| Ingredients: | 97 |
| NDAs: | 167 |
Drugs and US Patents for Sun Pharm Industries
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 081049-001 | Jun 5, 1990 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Industries | SULINDAC | sulindac | TABLET;ORAL | 072051-001 | Apr 17, 1991 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Industries | DOXYCYCLINE | doxycycline | TABLET;ORAL | 065471-003 | Apr 17, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 089382-001 | May 19, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 040527-001 | Oct 23, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | ULTRAVATE | halobetasol propionate | LOTION;TOPICAL | 208183-001 | Nov 6, 2015 | RX | Yes | Yes | 8,962,028 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm Industries
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| Sun Pharm Industries | BACTRIM DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| Sun Pharm Industries | BACTRIM PEDIATRIC | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Sun Pharm Industries Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201502692 | ⤷ Try a Trial |
| Eurasian Patent Organization | 029494 | ⤷ Try a Trial |
| Japan | 2015534980 | ⤷ Try a Trial |
| South Korea | 20150069005 | ⤷ Try a Trial |
| Mexico | 2015004863 | ⤷ Try a Trial |
| Philippines | 12015500859 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Industries Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2217577 | 19C1004 | France | ⤷ Try a Trial | PRODUCT NAME: ALLOPURINOL/LESINURAD OU UN/DES SEL(S) PHARMACEUTIQUEMENT ACCEPTABLE(S) DE CELUI-CI; REGISTRATION NO/DATE: EU/1/18/1300 20180827 |
| 1602370 | 09C0020 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON COMRENANT L’ALISKIREN SOUS FORME DE BAE LIBRE OU UN SEL DE CELUI-CI PHARMACEUTIQUEMENT ACCEPTABLE, ET L’HYDROCHLOROTHIAZIDE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE IN FRANCE: EU/1/08/491/001 DU 20090116; REGISTRATION NO/DATE AT EEC: 58935 01-04 DU 20081028 |
| 2236132 | C300714 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
| 1915993 | C300625 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414 |
| 2236132 | 122015000006 | Germany | ⤷ Try a Trial | PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718 |
| 1412357 | C300357 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SITAGLIPTINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZOUT, IN HET BIJZONDER HET MONOFOSFAAT, EN METFORMINE DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
